Search

everythinglearnresearchcommunity

for

Search:↓

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Stem cells from hair follicles can safely treat hair loss.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

AGA can occur in children with family history; early diagnosis and treatment important.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Finasteride increases hair weight and count in men with hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Multiple treatments work best for hair loss.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

DHT, a testosterone byproduct, causes male pattern baldness.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Finasteride works better than Serenoa repens for male hair loss.